Understanding how epithelial cells maintain their structure and function
Role of Membrane Trafficking in Epithelial Homeostasis
This study looks at how certain cells in our body keep their shape and function properly, especially after they've been damaged, by focusing on a protein that helps move important receptors to the right spots on the cell surface, which could help us understand and improve treatments for conditions like cancer and kidney disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10988316 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which epithelial cells, which are essential for nutrient absorption and waste secretion, maintain their polarized structure. It focuses on the role of a specific protein complex, AP-1B, in sorting and recycling cell surface receptors to the correct parts of the cell membrane. By studying how these processes are regulated, especially after tissue damage, the research aims to uncover insights into diseases linked to cell polarity loss, such as cancer and kidney disease. Patients may benefit from a better understanding of how to restore normal cell function in various conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to epithelial cell polarity loss, such as metastatic cancer, polycystic kidney disease, or Crohn’s disease.
Not a fit: Patients with conditions unrelated to epithelial cell function or those without epithelial cell involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases associated with epithelial cell dysfunction.
How similar studies have performed: Previous research has shown promising results in understanding cell polarity and its implications for various diseases, indicating that this approach has potential for success.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Folsch, Heike — Northwestern University at Chicago
- Study coordinator: Folsch, Heike
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.